Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
08 2021
Historique:
received: 28 01 2021
revised: 21 06 2021
accepted: 21 06 2021
pubmed: 26 6 2021
medline: 15 12 2021
entrez: 25 6 2021
Statut: ppublish

Résumé

The human cytidine deaminase family of APOBEC3s (A3s) plays critical roles in both innate immunity and the development of cancers. A3s comprise seven functionally overlapping but distinct members that can be exploited as nucleotide base editors for treating genetic diseases. Although overall structurally similar, A3s have vastly varying deamination activity and substrate preferences. Recent crystal structures of ssDNA-bound A3s together with experimental studies have provided some insights into distinct substrate specificities among the family members. However, the molecular interactions responsible for their distinct biological functions and how structure regulates substrate specificity are not clear. In this study, we identified the structural basis of substrate specificities in three catalytically active A3 domains whose crystal structures have been previously characterized: A3A, A3B- CTD, and A3G-CTD. Through molecular modeling and dynamic simulations, we found an interdependency between ssDNA substrate binding conformation and nucleotide sequence specificity. In addition to the U-shaped conformation seen in the crystal structure with the CTC

Identifiants

pubmed: 34171358
pii: S0021-9258(21)00709-2
doi: 10.1016/j.jbc.2021.100909
pmc: PMC8313598
pii:
doi:

Substances chimiques

DNA, Single-Stranded 0
APOBEC Deaminases EC 3.5.4.5
APOBEC3 proteins, human EC 3.5.4.5

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

100909

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150478
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM118474
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no conflict of interest.

Auteurs

Shurong Hou (S)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Jeong Min Lee (JM)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Wazo Myint (W)

Basic Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Hiroshi Matsuo (H)

Basic Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Nese Kurt Yilmaz (N)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Electronic address: Nese.KurtYilmaz@umassmed.edu.

Celia A Schiffer (CA)

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Electronic address: Celia.Schiffer@umassmed.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH